Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиКвартальный отчет 2024-Q3
добавлен 06.11.2024
Oncternal Therapeutics Мультипликаторы 2011-2024 | ONCT
Мультипликаторы по годам Oncternal Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.7 | -0.1 | -2.9 | -6.3 | -1.1 | -0.5 | -9.0 | -4.4 | -5.0 | -1.3 | -2.7 | -11.4 | -10.1 |
P/S |
34.8 | 1.6 | 21.4 | 32.3 | 15.8 | - | - | - | - | - | - | - | 22.9 |
EPS |
-13.4 | -16.8 | -0.6 | -0.8 | -3.3 | -1.8 | -1.8 | -1.2 | -0.1 | -0.5 | -0.7 | -0.4 | -0.6 |
EV (Enterprise Value) |
27.3 млн | -27.1 млн | 1.47 млн | -2 млн | 25.8 млн | -2.04 млн | 267 млн | 73.9 млн | 110 млн | 64.8 млн | 104 млн | 270 млн | 280 млн |
EBITDA per Share |
-14.2 | -17.1 | -0.64 | -0.872 | -1.44 | -11.7 | -12.3 | -12.5 | -10.9 | -25.9 | -48 | -54.6 | -39.8 |
EV/EBITDA |
1.3 | 0.4 | -1.2 | 0.2 | -8.5 | -2.7 | -3.7 | -1.1 | -2.3 | -5.3 | -8.4 | ||
PEG |
-0.0 | -0.0 | 0.09 | -0.13 | -0.02 | -0.1 | 0.21 | -0.72 | -0.07 | -0.04 | 0.05 | -0.44 | 0.04 |
P/B |
0.9 | 0.0 | 1.0 | 1.0 | 2.7 | 0.8 | 7.2 | 3.9 | 50.6 | 2.8 | 10.6 | 6.5 | 4.7 |
P/CF |
-0.8 | -0.1 | -3.5 | -6.2 | -2.3 | -0.5 | -11.7 | -3.7 | -4.7 | -1.7 | -2.6 | -8.3 | -10.2 |
ROE % |
-131.37 | -72.45 | -35.56 | -15.25 | -238.88 | -147.13 | -79.56 | -89.11 | -1006.08 | -221.05 | -394.15 | -56.76 | -46.32 |
ROA % |
-107.49 | -64.34 | -33.48 | -14.50 | -157.23 | -122.66 | -65.83 | -72.34 | -58.39 | -77.81 | -269.86 | -46.86 | -42.58 |
ROCE % |
-138.81 | -73.72 | -35.59 | -15.53 | -104.28 | -149.59 | -80.12 | -130.38 | -1174.88 | -169.93 | -394.99 | -103.01 | -46.72 |
Current Ratio |
5.5 | 8.9 | - | 20.1 | 2.8 | 6.0 | 5.8 | 5.3 | 1.1 | 1.5 | 3.3 | 6.0 | 12.6 |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | 24.3 |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | 55.7 |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | 421.7 |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | 80.0 |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | -341.7 |
Все данные представлены в валюте USD
Мультипликаторы поквартально Oncternal Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-2.86 | -2.89 | -2.83 | - | -3.35 | -3.05 | -3.93 | - | -0.21 | -0.23 | -0.2 | - | -0.19 | -0.16 | -0.12 | - | -0.22 | -0.34 | -0.31 | - | -0.32 | -3.38 | -0.62 | -0.23 | -0.53 | -0.68 | -0.62 | -0.43 | -0.53 | -0.4 | -0.39 | -0.44 | -0.49 | -0.43 | 0.15 | -0.23 | 2.48 | -3.42 | -0.17 | -0.13 | -0.06 | -0.15 | -0.14 | -0.12 | -0.14 | -0.2 | -0.2 | -0.17 | 0.08 | -0.17 | -0.18 | -0.17 | -0.15 | -0.21 | -0.05 |
EBITDA per Share |
- | - | - | - | - | - | - | - | -0.21 | -0.24 | -0.2 | - | -0.2 | -0.16 | -0.12 | - | -0.22 | -341 | -309 | - | -323 | -3.2 тыс. | -638 | -0.23 | -536 | -711 | -0.62 | -0.44 | -0.53 | -0.4 | -0.39 | -0.44 | -0.49 | -0.43 | -0.43 | -0.42 | -0.42 | -0.35 | -0.36 | -0.05 | -0.06 | -0.14 | -0.13 | -0.15 | -0.14 | -0.2 | -0.2 | -0.21 | -0.19 | -0.18 | -0.19 | -0.19 | -0.16 | -0.19 | -0.04 |
ROE % |
-210.10 | -144.23 | -109.74 | -68.38 | -84.61 | -74.19 | -70.21 | -44.45 | -54.64 | -48.60 | -40.23 | -23.18 | -27.07 | -20.77 | -18.17 | -12.99 | -47.17 | -77.46 | -232.19 | -209.84 | -191.56 | -150.98 | 16.79 | 27.11 | 48.69 | 20.06 | -4.82 | -15.46 | -89.82 | -102.35 | -116.04 | -89.11 | -228.51 | 1681.78 | -867.25 | -1006.08 | -913.75 | -2816.95 | -298.88 | -221.05 | -223.12 | -279.09 | -337.53 | -321.24 | -343.70 | -249.36 | -151.30 | -56.76 | -49.16 | -72.85 | -65.94 | -46.32 | -13.00 | -14.85 | -3.61 |
ROA % |
-141.74 | -110.32 | -92.11 | -60.20 | -74.81 | -66.58 | -63.32 | -40.59 | -50.19 | -45.19 | -37.87 | -21.90 | -25.60 | -19.70 | -17.27 | -12.35 | -34.84 | -53.64 | -154.05 | -138.12 | -162.77 | -148.92 | -54.83 | -49.04 | -44.45 | -54.20 | -57.07 | -65.83 | -73.78 | -83.61 | -94.46 | -72.34 | -54.42 | 82.65 | -42.35 | -58.39 | -77.01 | -195.61 | -67.51 | -77.81 | -106.36 | -153.89 | -214.32 | -219.94 | -238.48 | -172.38 | -108.31 | -46.86 | -41.90 | -62.68 | -58.36 | -42.50 | -11.95 | -13.65 | -3.32 |
ROCE % |
-217.53 | -150.72 | -115.58 | -72.34 | -88.87 | -77.30 | -72.12 | -44.82 | -55.02 | -48.70 | -40.26 | -23.20 | -27.09 | -20.79 | -18.18 | -13.00 | -47.58 | -78.27 | -224.43 | -202.12 | -183.27 | -142.16 | 17.48 | -18.47 | 3.06 | -25.77 | -51.19 | -15.18 | -90.06 | -102.59 | -116.20 | -130.38 | -416.36 | -696.92 | -933.34 | -1174.88 | -884.99 | -597.40 | -391.93 | -170.22 | -225.52 | -281.59 | -340.22 | -408.08 | -349.23 | -292.12 | -196.49 | -104.26 | -93.90 | -82.29 | -72.60 | -49.95 | -15.15 | -14.70 | -3.39 |
Current Ratio |
2.4 | 2.9 | 4.7 | 5.5 | 7.0 | 9.1 | - | 8.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 51.0 | 47.5 | - | 44.1 | 54.4 | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 51.0 | 47.5 | - | 44.1 | 54.4 | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 51.0 | 47.5 | - | 44.1 | 54.4 | - |
Все данные представлены в валюте USD